JPMorgan Chase & Co
CLDI.WS

JPMorgan Chase & Co’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

JPMorgan Chase & Co’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Hold
0
– -$8K – 6022
2022
Q3 		– Hold
0
– -$15K – 5114
2022
Q2 		– Hold
0
– -$53K – 5108
2022
Q1 		– Hold
0
– – – 4997